Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Feld

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Annals of Intensive Care|December 19, 2020
Characteristics and risk factors associated with critical illness in pediatric COVID-19Grace Fisler, Stephanie M Izard, Sareen Shah, et al.
Pediatrics|July 19, 2020
Early Experience of COVID-19 in a US Children's HospitalMundeep K Kainth, Pratichi K Goenka, Kristy A Williamson, et al.
Nature Communications|July 30, 2015
Loss of ATM accelerates pancreatic cancer formation and epithelial-mesenchymal transitionRonan Russell, Lukas Perkhofer, Stefan Liebau, et al.
British Journal of Cancer|May 6, 2025
Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre studyThomas F Stoop, Y H Andrew Wu, Atsushi Oba, et al.
JAMA Oncology|January 23, 2025
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOXThomas F Stoop, Toshitaka Sugawara, Atsushi Oba, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Annals of Intensive Care|December 19, 2020
Characteristics and risk factors associated with critical illness in pediatric COVID-19Grace Fisler, Stephanie M Izard, Sareen Shah, et al.
Pediatrics|July 19, 2020
Early Experience of COVID-19 in a US Children's HospitalMundeep K Kainth, Pratichi K Goenka, Kristy A Williamson, et al.
Nature Communications|July 30, 2015
Loss of ATM accelerates pancreatic cancer formation and epithelial-mesenchymal transitionRonan Russell, Lukas Perkhofer, Stefan Liebau, et al.
British Journal of Cancer|May 6, 2025
Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre studyThomas F Stoop, Y H Andrew Wu, Atsushi Oba, et al.
JAMA Oncology|January 23, 2025
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOXThomas F Stoop, Toshitaka Sugawara, Atsushi Oba, et al.
Pageof 7